Contrasting effects of dopamine antagonists and frequency reduction on Fos expression induced by lateral hypothalamic stimulation

Behavioural Brain Research

Volumn 132, Issue 2, 2002, Pages 187-201

  Hunt, Glenn E ^a,b   McGregor, Iain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Brain stimulation reward; c Fos; Dopamine; Frequency reduction; Medial forebrain bundle; Nucleus accumbens; SCH 23390; Spiperone

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SPIRONOLACTONE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ELECTRODE; ELECTROSTIMULATION; EXTRAPYRAMIDAL SYMPTOM; FOREBRAIN; FREQUENCY MODULATION; HYPOTHALAMUS NUCLEUS; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; REDUCTION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BRAIN CHEMISTRY; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; GENE EXPRESSION REGULATION; GENES, FOS; HYPOTHALAMIC AREA, LATERAL; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, WISTAR; REWARD; SELF STIMULATION; SPIPERONE;

EID: 0037076458     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(01)00441-7     Document Type: Article

References (98)

1. Dopaminergic regulation of progesterone receptors: Brain D5 dopamine receptors mediate induction of lordosis by D1-like agonists in rats
2. Increased ipsilateral expression of Fos following lateral hypothalamic self-stimulation
3. Fos-like immunoreactivity in the caudal diencephalon and brainstem following lateral hypothalamic self-stimulation
4. Fos expression following self-stimulation of the medial prefrontal cortex
5. Dissociating the determinants of self-stimulation
6. A dopamine D-1 agonist elevates self-stimulation thresholds: Comparison to other dopamine-selective drugs
7. Functional heterogeneity in dopamine release and in the expression of Fos-like proteins within the rat striatal complex
8. Dopamine D1-like receptors and reward-related incentive learning
9. 3 receptor agonists
10. The relationship of pharmacology to side effects
11. Burst stimulation of the medial forebrain bundle selectively increases Fos-like immunoreactivity in the limbic forebrain of the rat
12. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics
13. 1 dopamine receptor activation of multiple transcription factor genes in rat striatum
14. 1 receptors in the striatum: Different interactions with the dopaminergic system
15. 3 receptors
16. 'When a rat smells a cat': The distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor
17. D1 dopamine receptor-deficient mouse: Cocaine-induced regulation of immediate-early gene and substance P expression in the striatum
18. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons
19. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety
20. Prefrontal cortex infusions of SCH 23390 cause immediate and delayed effects on ventral tegmental area stimulation reward
21. Changes in local cerebral glucose utilization during rewarding brain stimulation
22. Dopamine, neuroleptics and reinforced behavior
23. Fos-like immunoreactivity in forebrain regions following self-stimulation of the lateral hypothalamus and the ventral tegmental area
24. 2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation
25. Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation
26. Forebrain origins and terminations of the medial forebrain bundle metabolically activated by rewarding stimulation or by reward-blocking doses of pimozide
27. A portrait of the substrate for self-stimulation
28. Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation
29. 14C-2-deoxyglucose analysis
30. Drugs of abuse and immediate-early genes in the forebrain
31. Induction of Fos protein by 3,4-methylenedioxymethamphetamine (Ecstasy) in rat brain: Regional differences in pharmacological manipulation
32. Selective permeation of the blood-brain barrier as a cause of the anomalous properties of 'atypical' neuroleptics
33. Inducible and constitutive transcription factors in the mammalian nervous system: Control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins
34. 2 dopamine receptors
35. The D1 dopamine receptor antagonist, SCH 23390 reduces locomotor activity and rearing in rats
36. Effect of tetrahydropalmatine analogs on Fos expression induced by formalin-pain
37. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system
38. D2/D1 ratio in the medial preoptic area affects copulation of male rats
39. Parametric manipulations and fixed-interval self-stimulation
40. Reward summation and the effects of pimozide, clonidine, and amphetamine on fixed-interval responding for brain stimulation
41. 2 agonists and antagonists on fixed-interval responding for brain stimulation
42. Rewarding brain stimulation induces only sparse Fos-like immunoreactivity in dopaminergic neurons
43. Immunohistochemical characterisation of Fos-positive cells in brainstem monoaminergic nuclei following intracranial self-stimulation of the medial forebrain bundle in the rat
44. A review of the pharmacology of new antipsychotic drugs
45. Behavioral effects of clozapine and dopamine receptor subtypes
46. Are animal studies of antipsychotics appropriately dosed?: Lessons from the bedside to the bench
47. 1 receptor and is dependent on NMDA stimulation
48. Extracellular dopamine dynamics in rat caudate-putamen during experimenter-delivered and intracranial self-stimulation
49. Real time measurement of stimulated dopamine release in the conscious rat using fast cyclic voltammetry-dopamine release is not observed during intracranial self stimulation
50. 2/1C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: Evidence for involvement of dorsal raphe nucleus projection fibres
51. 1 antagonist and of sexual experience on copulation-induced Fos-like immunoreactivity in the medial preoptic nucleus
52. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja
53. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors
54. 9-THC and anandamide induced c-fos expression in the rat forebrain
55. The curve-shift paradigm in self-stimulation
56. 9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain
57. Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis
58. Regional differences in desensitization of c-Fos expression following repeated self-stimulation of the medial forebrain bundle in the rat
59. Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390
60. The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat
61. The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat
62. 1 receptor agonist SKF-82958 in the rat striatum
63. Ventral pallidum self-stimulation induces stimulus dependent increase in c-fos expression in reward-related brain regions
64. Activation of brainstem catecholaminergic neurons by conditioned and unconditioned aversive stimuli as revealed by c-Fos immunoreactivity
65. Induction of c-Fos immunoreactivity in the rat forebrain by conditioned and unconditioned aversive stimuli
66. Implications of immediate-early gene induction in the brain following sexual stimulation of female and male rodents
67. Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses
68. 2a receptors in the induction of c-Fos expression by clozapine and haloperidol
69. Metabolic mapping of the brain during rewarding self-stimulation
70. The distribution of changes in local cerebral energy metabolism associated with brain stimulation reward to the medial forebrain bundle of the rat
71. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine
72. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity
73. Sexual behavior increases c-fos expression in the forebrain of the male rat
74. Increase of extracellular glutamate and expression of Fos-like immunoreactivity in the ventral tegmental area in response to electrical stimulation of the prefrontal cortex
75. New insights into dopaminergic receptor function using antisense and genetically altered animals
76. Medial forebrain bundle lesions fail to structurally and functionally disconnect the ventral tegmental area from many ipsilateral forebrain nuclei - Implications for the neural substrate of brain stimulation reward
77. Regulation of rat cortex function by D1 dopamine receptors in the striatum
78. The distribution of 3,4-methylenedioxymethamphetamine 'ecstasy'-induced c-fos expression in rat brain
79. 1-like dopamine receptors
80. Drugs of abuse and brain gene expression
81. Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists
82. Differences in the cataleptogenic actions of SCH23390 and selected classical neuroleptics
83. 7-OH-DPAT differentially reverses clozapine- and haloperidol-induced increases in Fos-like immunoreactivity in the rodent forebrain
84. Structure and function of dopamine receptors
85. 1 dopamine receptor agonist SKF-82958 in the intact rat striatum
86. Brain reinforcement mechanisms: Alpha-adrenergic and dopaminergic agonists and antagonists
87. 1 dopamine receptors mediate neuroleptic-induced Fos expression in the islands of Calleja
88. Dopamine antagonists induce fos-like-immunoreactivity in the substantia nigra and entopeduncular nucleus of the rat
89. Neuroleptics and operant behavior: The anhedonia hypothesis
90. Addictive drugs and brain stimulation reward
91. Activation of single neurons in the rat nucleus accumbens during self-stimulation of the ventral tegmental area
92. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor
93. Unilaterally activated systems in rats self-stimulating at sites in the medial forebrain bundle, medial prefrontal cortex, or locus coeruleus
94. 1 receptors
95. 2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy